VERONIKA LEONENKO: Open Payments
NPI 1306300199 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 26 payments from 13 companies in 2025. Trend: 2023 $801 · 2024 $826 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $57 |
| PFIZER INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Amgen Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Wegovy, Kerendia, Ozempic, CAPLYTA, GARDASIL 9, KRYSTEXXA, ELIQUIS, MOUNJARO.
Industry payments across VA — which companies pay providers there.
